Rare Disease Patients Still Waiting for Crowdfunding Plan in India
source: pixabay.com

Rare Disease Patients Still Waiting for Crowdfunding Plan in India

As we know, many treatments for rare diseases are quite expensive - and this price doesn't even factor in travel, lodging, appointments, and more. To help with this, the government…

Continue Reading Rare Disease Patients Still Waiting for Crowdfunding Plan in India
A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
source: pixabay.com

A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon

According to a story from Globe Newswire, The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recently announced a positive opinion in regards to the experimental…

Continue Reading A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV
qimono / Pixabay

Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

The new FDA-approved oral formulation of  Radicava ORS (edaravone) is more convenient than the intravenous formulation, yet the efficacy and composition remain the same. The oral formulation may also be…

Continue Reading Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

Rare Disease Clinical Trials Are Essential to Help Uncover Potential Patient Solutions: Spotlight on Classic Congenital Adrenal Hyperplasia (CAH)

Acknowledgment: This story is sponsored by Neurocrine Biosciences and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant, vetted,…

Continue Reading Rare Disease Clinical Trials Are Essential to Help Uncover Potential Patient Solutions: Spotlight on Classic Congenital Adrenal Hyperplasia (CAH)
FDA Approved: Cuvrior for Wilson Disease
https://unsplash.com/photos/_jbClosDsD4

FDA Approved: Cuvrior for Wilson Disease

For the last 52 years, individuals with Wilson disease have been relying, largely, on the same treatment options. These options, designed to remove copper from the body, include Cuprimine (penicillamine).…

Continue Reading FDA Approved: Cuvrior for Wilson Disease
Study of Patients With Metastatic Renal Cell Carcinoma and Sarcopenia Finds Reduced Survival Following Cytoreductive Nephrectomy
source: pixabay.com

Study of Patients With Metastatic Renal Cell Carcinoma and Sarcopenia Finds Reduced Survival Following Cytoreductive Nephrectomy

As featured recently in the Cancer Therapy Advisor, a study has been conducted on patients diagnosed with metastatic renal cell carcinoma (mRCC), who also have elevated inflammation, and sarcopenia. The…

Continue Reading Study of Patients With Metastatic Renal Cell Carcinoma and Sarcopenia Finds Reduced Survival Following Cytoreductive Nephrectomy
Study Highlights Experiences of Patients Treated with ADV7103 for Distal Renal Tubular Acidosis
source: pixabay.com

Study Highlights Experiences of Patients Treated with ADV7103 for Distal Renal Tubular Acidosis

According to a recent article, a new study is demonstrating how the effects of distal renal tubular acidosis impact a patient’s quality of life. Distal Renal Tubular Acidosis (dRTA) Distal…

Continue Reading Study Highlights Experiences of Patients Treated with ADV7103 for Distal Renal Tubular Acidosis
Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease
source: pixabay.com

Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease

  Every year almost half of the fourteen thousand patients who have received bone marrow or stem cell transplants will develop chronic graft-versus-host disease (cGVHD). Currently, there are no options…

Continue Reading Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease
Researchers Investigate Pentosan Polysulfate Sodium to Treat Maroteaux-Lamy Syndrome
source: pixabay.com

Researchers Investigate Pentosan Polysulfate Sodium to Treat Maroteaux-Lamy Syndrome

  According to a recent article, researchers at the WORLDSymposium revealed they are looking into using pentosan polysulfate sodium to treat Maroteaux-Lamy syndrome. MPS VI (Maroteaux-Lamy Syndrome) Maroteaux-Lamy syndrome is…

Continue Reading Researchers Investigate Pentosan Polysulfate Sodium to Treat Maroteaux-Lamy Syndrome